C(=O)([O-])[O-].[Cs+].[Cs+].Cl[CH2:8][C:9]1[C:18]2[C:13](=[CH:14][CH:15]=[CH:16][CH:17]=2)[N:12]=[C:11]([CH3:19])[CH:10]=1.[I-].[K+].[OH:22][C:23]1[CH:28]=[CH:27][C:26]([S:29]([NH:32][CH2:33][C@H:34]([N:39]2[CH2:44][CH2:43][N:42]([S:45]([CH3:48])(=[O:47])=[O:46])[CH2:41][CH2:40]2)[C:35]([O:37][CH3:38])=[O:36])(=[O:31])=[O:30])=[CH:25][CH:24]=1>CC(C)=O>[CH3:48][S:45]([N:42]1[CH2:41][CH2:40][N:39]([C@@H:34]([CH2:33][NH:32][S:29]([C:26]2[CH:25]=[CH:24][C:23]([O:22][CH2:8][C:9]3[C:18]4[C:13](=[CH:14][CH:15]=[CH:16][CH:17]=4)[N:12]=[C:11]([CH3:19])[CH:10]=3)=[CH:28][CH:27]=2)(=[O:31])=[O:30])[C:35]([O:37][CH3:38])=[O:36])[CH2:44][CH2:43]1)(=[O:46])=[O:47]280 mg (0.85 mmol) of cesium carbonate followed by 160 mg (0.85 mmol) of 4-chloromethyl-2-methylquinoline and by 15 mg of potassium iodide are added to a solution of 300 mg (0.71 mmol) of methyl (S)-3-(4-hydroxybenzenesulfonylamino)-2-(4-methanesulfonylpiperazin-1-yl)propanoate in 10 ml of acetone. The reaction medium is stirred at ambient temperature for 18 h, filtered and concentrated under vacuum. The crude product is purified by chromatography on silica gel, elution being carried out with a 40/60 heptane/ethyl acetate mixture. 130 mg (32%) of methyl (S)-2-(4-methanesulfonylpiperazin-1-yl)-3-[4-(2-methylquinolin-4-ylmethoxy)benzenesulfonylamino]propanoate are obtained in the form of a white solid.
Wird geladen…